Holen Sie sich die Stockscreener-App
176.20
0.20%
-0.36
Handel nachbörslich:
176.20
Schlusskurs vom Vortag:
$176.56
Offen:
$178.08
24-Stunden-Volumen:
216.74K
Relative Volume:
0.51
Marktkapitalisierung:
$5.66B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-36.26
EPS:
-4.86
Netto-Cashflow:
$-87.43M
1W Leistung:
+0.34%
1M Leistung:
-3.21%
6M Leistung:
+78.36%
1J Leistung:
+207.08%
1-Tages-Spanne:
$176.01
$180.42
1-Wochen-Bereich:
$174.37
$182.60
52-Wochen-Spanne:
$55.92
$187.57
Irhythm Technologies Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Technologies Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
176.20 | 5.67B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
How iRhythm Technologies Inc. (I25) stock reacts to new regulationsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Baird Maintains iRhythm Technologies (IRTC) Outperform Recommendation - Nasdaq
Baird Raises Price Target for iRhythm Technologies (IRTC) to $22 - GuruFocus
What drives iRhythm Technologies Inc I25 stock priceCapital Gains Strategies & Unlock Smart Investment Tactics That Work - earlytimes.in
How resilient is iRhythm Technologies Inc. stock in market downturns2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
iRhythm Technologies $IRTC Shares Sold by Blair William & Co. IL - MarketBeat
We Think IRhythm Technologies (NASDAQ:IRTC) Has A Fair Chunk Of Debt - 富途牛牛
How to use Fibonacci retracement on iRhythm Technologies Inc.2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com
Understanding iRhythm Technologies Inc.’s price movementChart Signals & Smart Money Movement Tracker - newser.com
Historical volatility pattern of iRhythm Technologies Inc. visualizedEarnings Beat & Risk Controlled Stock Alerts - newser.com
iRhythm Technologies' (IRTC) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Will iRhythm Technologies Inc. see short term momentumBear Alert & Accurate Buy Signal Notifications - newser.com
Is iRhythm Technologies Inc. stock a defensive play in 2025Weekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Citigroup Maintains iRhythm Technologies (IRTC) Buy Recommendation - Nasdaq
Citigroup Raises Price Target for iRhythm Technologies (IRTC) to $205 | IRTC Stock News - GuruFocus
Evercore ISI Group Lowers Price Target for iRhythm Technologies (IRTC) | IRTC Stock News - GuruFocus
Evercore ISI Cuts iRhythm Technologies (NASDAQ:IRTC) Price Target to $175.00 - MarketBeat
Medical technology stock picks for a ‘cautious’ Q3: analysts - Proactive financial news
Multi asset correlation models including iRhythm Technologies Inc.Portfolio Value Report & Low Drawdown Investment Strategies - newser.com
Is iRhythm Technologies Inc. stock reversal real or fakeMarket Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Sentiment analysis tools applied to iRhythm Technologies Inc.2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Published on: 2025-10-06 02:07:09 - newser.com
What does recent volatility data suggest for iRhythm Technologies Inc.Portfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks - The Globe and Mail
Published on: 2025-10-05 01:42:03 - newser.com
Does Regulatory Scrutiny and Legal Action Challenge the Zio Platform Outlook for iRhythm Technologies (IRTC)? - Sahm
Why Analysts Are Rethinking the Growth Story for iRhythm Technologies After Recent Industry Shifts - Yahoo
How Regulatory and Legal Hurdles Will Impact iRhythm Technologies (IRTC) Investors - Yahoo Finance
iRhythm Technologies (IRTC): Valuation Check Following FDA Warning Letter and Compliance Lawsuit - Sahm
Exit strategy if you’re trapped in iRhythm Technologies Inc.July 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Custom strategy builders for tracking iRhythm Technologies Inc.2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com
Applying big data sentiment scoring on iRhythm Technologies Inc.Portfolio Update Report & Verified Momentum Stock Alerts - newser.com
2 Healthcare Stocks to Research Further and 1 Facing Challenges - Yahoo Finance
Intraday pattern recognizer results for iRhythm Technologies Inc.Market Volume Report & Expert Curated Trade Setups - newser.com
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know - Yahoo Finance
The Goldman Sachs Group Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - Defense World
Goldman Sachs Maintains iRhythm Technologies (IRTC) Neutral Recommendation - Nasdaq
Goldman Sachs Raises Price Target for IRTC, Maintains Neutral Ra - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Shares Down 6.8%What's Next? - MarketBeat
Regression analysis insights on iRhythm Technologies Inc. performanceGlobal Markets & Weekly Momentum Picks - newser.com
1 Cash-Producing Stock with Competitive Advantages and 2 We Question - The Globe and Mail
iRhythm Technologies, Inc. (IRTC) Shares Surge 96% Despite FDA Warning and Legal Challenges - MSN
Finanzdaten der Irhythm Technologies Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Irhythm Technologies Inc-Aktie (IRTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wilson Daniel G. | Chief Financial Officer |
Sep 02 '25 |
Sale |
167.28 |
737 |
123,285 |
39,470 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):